Conservative management of cicatrix after circumcision: Retraction and steroid

Aim: Our study aims to study the combined manual retracting and topical steroid application method for the treatment of postcircumcision cicatrix in neonates and infants and to establish the need for a secondary intervention.Material and Methods: A total of 20 patients applying to our clinic with post-circumcision cicatrix between April 2018 and January2019 were evaluated retrospectively. Multivariable analyses assessed the association between the age of the patients and the onsetof complaints associated with cicatrix, the time to onset of symptoms, and the duration of recovery.Results: The mean age at admission was 7.8 months (4-13 months), and the mean age at circumcision was 3.4 months (2 weeks-6months). In our study, all the patients had been fully recovered after the treatment with combination of topical 0.1% betamethasoneointment and manual retraction. The mean duration of treatment was 30.6 days (14-56 days).Conclusion: In this study, we reported our observations related to the treatment only with 0.1% Betamethasone ointment and manualretraction for the first time in the literature. We believe that before choosing secondary applications which potentially traumatize thepatient, insisting on topical steroid and manual retraction will provide a satisfactory outcome.

PDF

___

1. Introcaso CE, Xu F, Kilmarx PH, et al. Prevalence of circumcision among men and boys aged 14 to 59 years in the United States, National Health and Nutrition Examination Surveys 2005- 2010. Sex Transm Dis 2013;40:521-5.
2. Tobian AA, Gray RH. The Medical benefits of male circumcision. JAMA 2011;306:1479–80.
3. Wheleer R, Malone P. Male circumcision: risk versus benefit. Arch Dis Child 2013;98: 321-2.
4. Hayashi Y, Kojima Y, Mizuno K, et al. Prepuce: Phimosis, paraphimosis, and circumcision. Scientific World J 2011;11:289-301.
5. Zhang L, Qin H, Wu Z, et al. Identification of the potential targets for keloid and hypertrophic scar prevention. J Dermatolog Treat 2018;29:600-5.
6. Letendre J, Barrieras D, Franc-Guimond J, et al. Topical triamcinolone for persistent phimosis. J Urol 20019;182:1759-63.
7. Liu J, Yang J, Chen Y, et al. Is steroids therapy effective in treating phimosis? A meta-analysis. Int Urol Nephrol 2016;48:335-42.
8. Nobre YD, Freitas RG, Felizardo MJ, et al. To Circ or Not to Circ: Clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision. Int Braz J Urol 2010;36:75-85.
9. Alpert SA, Ching CB, DaJusta DG, et al.Combination treatment for cicatrix after neonatal circumcision: An office-based solution to a challenging problem. J Pediatr Urol 2018;14:471-5.
10. Blalock HJ, Vemulakonda V, Ritchey ML, et al. Outpatient management of phimosis following newborn circumcision. J Urol 2003;169:2332-4.
11. Casale AJ, Beck SD, Cain MP, et al. Concealed penis in childhood: a spectrum of etiology and treatment. J Urol 1999;162:1165-8.
12. Kidger EA, Haider N, Qazi A. Acquired phimosis after plastibell circumcision: a preventable consequence. Ann R Coll Surg Engl 2012;94:186–8.
13. Palmer JS, Elder JS, Palmer LS. The use of betamethasone to manage the trapped penis following neonatal circumcision. J Urol 2005;174:1577-8.
14. Sookpotarom P, Asawutmangkul C, Srinithiwat B, et al. Is half strength of 0.05% betamethasone valerate cream still effective in the treatment of phimosis in young children? Pediatr Surg Int 2013;29:393-6.